Improved survival for fallopian tube cancer: A comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer

Stephanie L. Wethington, Thomas J. Herzog, Venkatraman E. Seshan, Nisha Bansal, Peter B. Schiff, William M. Burke, Carmel J. Cohen, Jason D. Wright

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

BACKGROUND. Fallopian tube cancers are rare neoplasms. These malignancies are thought to behave biologically and clinically like ovarian cancer. The purpose of this study was to compare the clinical behavior and outcome of fallopian tube and ovarian cancer. METHODS. The Surveillance, Epidemiology, and End Results database was reviewed to identify women with tumors of the fallopian tube (FT) and ovary (OV) diagnosed between 1988 and 2004. Demographic and clinical data were compared, and the impact of tumor site on survival was analyzed using Cox models and the Kaplan-Meier method. RESULTS. A total of 55,825 patients were identified, 1576 (3%) with FT and 54,249 (97%) with OV cancer. FT patients were more likely to present with early stage tumors (P <.001). Among FT patients, 47% had stage I/II tumors compared with 29% of OV cancers. In an adjusted Cox model of all patients, cancer-specific mortality was 48% lower in FT patients (hazard ratio, 0.52; 95% confidence interval [CI], 0.48-0.56) compared with OV cancer. Among patients with FT tumors, advanced age and stage were independent predictors of decreased survival. When stratified by stage, survival was similar for stage I and II tumors, but stage III and IV FT patients had an improved survival. The 5-year survival for stage III FT cancer was 54% (95% CI, 48%-60%), compared with 30% (95% CI, 29%-31%) for OV. CONCLUSIONS. Fallopian tube cancers present earlier and at advanced stage have a better overall survival than primary ovarian malignancies. Future clinical trials should recognize the possible distinct clinical behavior of fallopian tube cancers.

Original languageEnglish (US)
Pages (from-to)3298-3306
Number of pages9
JournalCancer
Volume113
Issue number12
DOIs
StatePublished - Dec 15 2008
Externally publishedYes

Fingerprint

Fallopian Tube Neoplasms
Ovarian Neoplasms
Fallopian Tubes
Survival
Neoplasms
Confidence Intervals
Proportional Hazards Models
Ovary
Epidemiology

Keywords

  • BRCA mutations
  • Fallopian tube cancer
  • Ovarian cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Improved survival for fallopian tube cancer : A comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. / Wethington, Stephanie L.; Herzog, Thomas J.; Seshan, Venkatraman E.; Bansal, Nisha; Schiff, Peter B.; Burke, William M.; Cohen, Carmel J.; Wright, Jason D.

In: Cancer, Vol. 113, No. 12, 15.12.2008, p. 3298-3306.

Research output: Contribution to journalArticle

Wethington, SL, Herzog, TJ, Seshan, VE, Bansal, N, Schiff, PB, Burke, WM, Cohen, CJ & Wright, JD 2008, 'Improved survival for fallopian tube cancer: A comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer', Cancer, vol. 113, no. 12, pp. 3298-3306. https://doi.org/10.1002/cncr.23957
Wethington, Stephanie L. ; Herzog, Thomas J. ; Seshan, Venkatraman E. ; Bansal, Nisha ; Schiff, Peter B. ; Burke, William M. ; Cohen, Carmel J. ; Wright, Jason D. / Improved survival for fallopian tube cancer : A comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. In: Cancer. 2008 ; Vol. 113, No. 12. pp. 3298-3306.
@article{300edb0cab27464bbcd6357294fa7b86,
title = "Improved survival for fallopian tube cancer: A comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer",
abstract = "BACKGROUND. Fallopian tube cancers are rare neoplasms. These malignancies are thought to behave biologically and clinically like ovarian cancer. The purpose of this study was to compare the clinical behavior and outcome of fallopian tube and ovarian cancer. METHODS. The Surveillance, Epidemiology, and End Results database was reviewed to identify women with tumors of the fallopian tube (FT) and ovary (OV) diagnosed between 1988 and 2004. Demographic and clinical data were compared, and the impact of tumor site on survival was analyzed using Cox models and the Kaplan-Meier method. RESULTS. A total of 55,825 patients were identified, 1576 (3{\%}) with FT and 54,249 (97{\%}) with OV cancer. FT patients were more likely to present with early stage tumors (P <.001). Among FT patients, 47{\%} had stage I/II tumors compared with 29{\%} of OV cancers. In an adjusted Cox model of all patients, cancer-specific mortality was 48{\%} lower in FT patients (hazard ratio, 0.52; 95{\%} confidence interval [CI], 0.48-0.56) compared with OV cancer. Among patients with FT tumors, advanced age and stage were independent predictors of decreased survival. When stratified by stage, survival was similar for stage I and II tumors, but stage III and IV FT patients had an improved survival. The 5-year survival for stage III FT cancer was 54{\%} (95{\%} CI, 48{\%}-60{\%}), compared with 30{\%} (95{\%} CI, 29{\%}-31{\%}) for OV. CONCLUSIONS. Fallopian tube cancers present earlier and at advanced stage have a better overall survival than primary ovarian malignancies. Future clinical trials should recognize the possible distinct clinical behavior of fallopian tube cancers.",
keywords = "BRCA mutations, Fallopian tube cancer, Ovarian cancer",
author = "Wethington, {Stephanie L.} and Herzog, {Thomas J.} and Seshan, {Venkatraman E.} and Nisha Bansal and Schiff, {Peter B.} and Burke, {William M.} and Cohen, {Carmel J.} and Wright, {Jason D.}",
year = "2008",
month = "12",
day = "15",
doi = "10.1002/cncr.23957",
language = "English (US)",
volume = "113",
pages = "3298--3306",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Improved survival for fallopian tube cancer

T2 - A comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer

AU - Wethington, Stephanie L.

AU - Herzog, Thomas J.

AU - Seshan, Venkatraman E.

AU - Bansal, Nisha

AU - Schiff, Peter B.

AU - Burke, William M.

AU - Cohen, Carmel J.

AU - Wright, Jason D.

PY - 2008/12/15

Y1 - 2008/12/15

N2 - BACKGROUND. Fallopian tube cancers are rare neoplasms. These malignancies are thought to behave biologically and clinically like ovarian cancer. The purpose of this study was to compare the clinical behavior and outcome of fallopian tube and ovarian cancer. METHODS. The Surveillance, Epidemiology, and End Results database was reviewed to identify women with tumors of the fallopian tube (FT) and ovary (OV) diagnosed between 1988 and 2004. Demographic and clinical data were compared, and the impact of tumor site on survival was analyzed using Cox models and the Kaplan-Meier method. RESULTS. A total of 55,825 patients were identified, 1576 (3%) with FT and 54,249 (97%) with OV cancer. FT patients were more likely to present with early stage tumors (P <.001). Among FT patients, 47% had stage I/II tumors compared with 29% of OV cancers. In an adjusted Cox model of all patients, cancer-specific mortality was 48% lower in FT patients (hazard ratio, 0.52; 95% confidence interval [CI], 0.48-0.56) compared with OV cancer. Among patients with FT tumors, advanced age and stage were independent predictors of decreased survival. When stratified by stage, survival was similar for stage I and II tumors, but stage III and IV FT patients had an improved survival. The 5-year survival for stage III FT cancer was 54% (95% CI, 48%-60%), compared with 30% (95% CI, 29%-31%) for OV. CONCLUSIONS. Fallopian tube cancers present earlier and at advanced stage have a better overall survival than primary ovarian malignancies. Future clinical trials should recognize the possible distinct clinical behavior of fallopian tube cancers.

AB - BACKGROUND. Fallopian tube cancers are rare neoplasms. These malignancies are thought to behave biologically and clinically like ovarian cancer. The purpose of this study was to compare the clinical behavior and outcome of fallopian tube and ovarian cancer. METHODS. The Surveillance, Epidemiology, and End Results database was reviewed to identify women with tumors of the fallopian tube (FT) and ovary (OV) diagnosed between 1988 and 2004. Demographic and clinical data were compared, and the impact of tumor site on survival was analyzed using Cox models and the Kaplan-Meier method. RESULTS. A total of 55,825 patients were identified, 1576 (3%) with FT and 54,249 (97%) with OV cancer. FT patients were more likely to present with early stage tumors (P <.001). Among FT patients, 47% had stage I/II tumors compared with 29% of OV cancers. In an adjusted Cox model of all patients, cancer-specific mortality was 48% lower in FT patients (hazard ratio, 0.52; 95% confidence interval [CI], 0.48-0.56) compared with OV cancer. Among patients with FT tumors, advanced age and stage were independent predictors of decreased survival. When stratified by stage, survival was similar for stage I and II tumors, but stage III and IV FT patients had an improved survival. The 5-year survival for stage III FT cancer was 54% (95% CI, 48%-60%), compared with 30% (95% CI, 29%-31%) for OV. CONCLUSIONS. Fallopian tube cancers present earlier and at advanced stage have a better overall survival than primary ovarian malignancies. Future clinical trials should recognize the possible distinct clinical behavior of fallopian tube cancers.

KW - BRCA mutations

KW - Fallopian tube cancer

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=57649138049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649138049&partnerID=8YFLogxK

U2 - 10.1002/cncr.23957

DO - 10.1002/cncr.23957

M3 - Article

C2 - 19006196

AN - SCOPUS:57649138049

VL - 113

SP - 3298

EP - 3306

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -